Cardiac resynchronisation therapy and AV nodal ablation trial in atrial fibrillation
This study is currently recruiting participants.
Primary Objective: In the current study, we aim to test the hypothesis that ablating the AV node, which controls electrical conduction from the heart's atria (top chamber) to its ventricles (lower chambers), will improve survival and heart failure symptoms in CRT patients with co-existent AF. The results are important, because they will provide a way of passing on the benefits of CRT, such as improved survival, less heart failure symptoms, and better quality of life, to heart failure patients who also suffer from AF.
Principal Investigator: Matthew Webber
Study Coordinators: Bronwyn Davies/ Beverley Scott
Trial Website: https://clinicaltrials.gov/ct2/show/NCT01522898